BioVie Inc (NASDAQ:BIVI, NASDAQ:BIVIW), a clinical-stage company developing therapies for neurological and neurodegenerative diseases, will host a live investor webinar on March 4 at 4:15 p.m Eastern Time, presented by RedChip Companies.
CEO Cuong Do will discuss BioVie’s lead drug candidate, bezisterim (NE3107), targeting inflammation and insulin resistance in Alzheimer’s, Parkinson’s, and Long COVID, as well as progress on BIV201 for cirrhosis and ascites. A live Q&A will follow.
Investors can register for the event here.